Labiana Health S.A (LAB) | Financial Analysis & Statements
Labiana Health S.A. Small-cap Healthcare
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Sep 2022Income Metrics
Revenue
10.6M
Gross Profit
15.6M
147.79%
Operating Income
9.1M
85.72%
Net Income
7.0M
66.63%
EPS (Diluted)
€0.02
Balance Sheet Metrics
Total Assets
54.4M
Total Liabilities
50.8M
Shareholders Equity
3.6M
Debt to Equity
14.09
Cash Flow Metrics
Operating Cash Flow
-7.2M
Free Cash Flow
-2.2M
Revenue & Profitability Trend
Quarter Income Flow
Sep 30, 2022
Annual Income Flow
2024
Labiana Health S.A Income Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 66.3M | 58.5M | 57.8M | 57.0M | 57.8M |
| Cost of Goods Sold | 25.3M | 24.1M | 25.2M | 22.0M | 23.8M |
| Gross Profit | 40.9M | 34.3M | 32.6M | 35.0M | 34.0M |
| Gross Margin % | 61.8% | 58.7% | 56.4% | 61.4% | 58.8% |
| Operating Expenses | |||||
| Research & Development | - | - | - | - | - |
| Selling, General & Administrative | - | - | 11.2M | 11.2M | 11.1M |
| Other Operating Expenses | 11.2M | 12.0M | 11.7M | 11.7M | 11.7M |
| Total Operating Expenses | 11.2M | 12.0M | 22.9M | 22.9M | 22.8M |
| Operating Income | 5.1M | -1.8M | -2.4M | 653.9K | 2.5M |
| Operating Margin % | 7.7% | -3.2% | -4.1% | 1.1% | 4.3% |
| Non-Operating Items | |||||
| Interest Income | 20.6K | 5.3K | 624.1K | 133.7K | 5.6K |
| Interest Expense | 4.8M | 3.3M | 2.1M | 2.1M | 1.9M |
| Other Non-Operating Income | - | - | - | - | - |
| Pre-tax Income | -30.0K | -5.3M | -7.8M | -2.1M | 541.2K |
| Income Tax | -236.5K | -776.0K | 1.3M | -13.3K | -532.5K |
| Effective Tax Rate % | 0.0% | 0.0% | 0.0% | 0.0% | -98.4% |
| Net Income | 206.5K | -4.5M | -9.1M | -2.1M | 1.1M |
| Net Margin % | 0.3% | -7.7% | -15.7% | -3.7% | 1.9% |
| Key Metrics | |||||
| EBITDA | 9.3M | 3.3M | 3.0M | 5.1M | 5.4M |
| EPS (Basic) | €0.04 | €-0.61 | €-1.24 | €-0.25 | €0.15 |
| EPS (Diluted) | €0.04 | €-0.61 | €-1.24 | €-0.25 | €0.15 |
| Basic Shares Outstanding | 7221255 | 7221255 | 7221255 | 7221255 | 7221255 |
| Diluted Shares Outstanding | 7221255 | 7221255 | 7221255 | 7221255 | 7221255 |
Income Statement Trend
Labiana Health S.A Balance Sheet From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Assets | |||||
| Current Assets | |||||
| Cash & Equivalents | 6.7M | 3.0M | 2.5M | 3.3M | 1.5M |
| Short-term Investments | 800 | 13.9K | 9.1K | 11.4K | 868.5K |
| Accounts Receivable | 9.4M | 11.8M | 8.8M | 7.9M | 10.5M |
| Inventory | 10.0M | 11.1M | 12.7M | 14.9M | 14.1M |
| Other Current Assets | - | 0 | - | - | - |
| Total Current Assets | 28.7M | 29.0M | 28.8M | 29.4M | 29.3M |
| Non-Current Assets | |||||
| Property, Plant & Equipment | 1.3M | 1.3M | 1.2M | 1.1M | 1.1M |
| Goodwill | 6.0M | 7.7M | 9.0M | 14.0M | 12.6M |
| Intangible Assets | 6.0M | 7.7M | 9.0M | 11.5M | 11.4M |
| Long-term Investments | - | - | - | - | - |
| Other Non-Current Assets | 0 | - | 0 | 0 | - |
| Total Non-Current Assets | 23.3M | 30.1M | 32.0M | 39.0M | 36.7M |
| Total Assets | 52.0M | 59.1M | 60.8M | 68.4M | 66.0M |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts Payable | 8.8M | 8.8M | 11.3M | 8.6M | 9.0M |
| Short-term Debt | 8.2M | 11.1M | 20.0M | 19.4M | 9.2M |
| Current Portion of Long-term Debt | - | - | - | - | - |
| Other Current Liabilities | - | - | - | - | 0 |
| Total Current Liabilities | 22.2M | 24.7M | 35.1M | 30.5M | 20.8M |
| Non-Current Liabilities | |||||
| Long-term Debt | 27.2M | 30.6M | 18.2M | 25.3M | 29.5M |
| Deferred Tax Liabilities | 33.1K | 357.4K | 399.3K | 322.9K | 545.7K |
| Other Non-Current Liabilities | 0 | 0 | 0 | - | - |
| Total Non-Current Liabilities | 27.3M | 31.0M | 18.8M | 26.4M | 30.9M |
| Total Liabilities | 49.4M | 55.7M | 53.9M | 56.8M | 51.7M |
| Equity | |||||
| Common Stock | 722.1K | 722.1K | 722.1K | 618.8K | 618.8K |
| Retained Earnings | 253.4K | -4.4M | -8.9M | -1.8M | 1.1M |
| Treasury Stock | 710.6K | 200.1K | 294.7K | 0 | - |
| Other Equity | - | - | - | - | - |
| Total Shareholders Equity | 2.6M | 3.4M | 6.9M | 11.5M | 14.3M |
| Key Metrics | |||||
| Total Debt | 35.4M | 41.7M | 38.2M | 44.8M | 38.6M |
| Working Capital | 6.5M | 4.3M | -6.3M | -1.0M | 8.5M |
Balance Sheet Composition
Labiana Health S.A Cash Flow Statement From 2020 to 2024
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | -30.0K | -5.3M | -7.8M | -2.1M | 541.2K |
| Depreciation & Amortization | - | - | - | - | - |
| Stock-Based Compensation | - | - | - | - | - |
| Working Capital Changes | 1.5M | 387.5K | 44.2K | 2.3M | -1.1M |
| Operating Cash Flow | 5.5M | -1.7M | -5.7M | 2.2M | 1.4M |
| Investing Activities | |||||
| Capital Expenditures | -3.0M | -1.6M | -2.8M | -2.3M | -4.2M |
| Acquisitions | -36.5K | 0 | 0 | 2.4M | -593.3K |
| Investment Purchases | -931.8K | -65.0K | -932.7K | -3.7M | 0 |
| Investment Sales | 29.0K | 556.4K | 3.4M | 0 | - |
| Investing Cash Flow | -4.0M | -1.2M | -274.6K | -4.8M | -4.8M |
| Financing Activities | |||||
| Share Repurchases | -158.9K | -158.6K | -412.1K | -1.1M | 0 |
| Dividends Paid | - | - | - | - | - |
| Debt Issuance | 4.4M | 19.5M | 736.7K | 1.8M | 4.6M |
| Debt Repayment | -3.6M | -16.3M | -7.4M | 0 | - |
| Financing Cash Flow | 571.7K | 4.3M | -5.6M | 5.1M | 2.9M |
| Free Cash Flow | 4.1M | -4.7M | -774.4K | -858.7K | -2.9M |
| Net Change in Cash | 2.1M | 1.5M | -11.6M | 2.5M | -457.7K |
Cash Flow Trend
Labiana Health S.A Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
42.50
Forward P/E
6.04
Price to Book
7.81
Price to Sales
0.60
PEG Ratio
6.04
Profitability Ratios
Profit Margin
1.26%
Operating Margin
13.02%
Return on Equity
23.11%
Return on Assets
7.43%
Financial Health
Current Ratio
1.42
Debt to Equity
998.21
Beta
-0.30
Per Share Data
EPS (TTM)
€0.12
Book Value per Share
€0.65
Revenue per Share
€10.25
Peer Financial Comparison
| Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
|---|---|---|---|---|---|---|
| LAB | 49.2M | 42.50 | 7.81 | 23.11% | 1.26% | 998.21 |
| Laboratorios | 4.3B | 36.12 | 6.59 | 22.33% | 18.89% | 18.04 |
| Almirall S.A | 2.8B | 58.64 | 1.86 | 3.10% | 4.14% | 23.30 |
| Faes Farma S.A | 1.5B | 19.60 | 2.05 | 10.82% | 12.70% | 58.11 |
| Laboratorio Reig | 220.6M | 45.17 | 1.01 | 2.30% | 1.49% | 42.21 |
| Grifols, S.A | 6.1B | 15.58 | 1.19 | 6.17% | 5.34% | 126.83 |
Financial data is updated regularly. All figures are in the company's reporting currency.





